UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Results Amid Growth and Challenges

2 min read | July 16, 2024 10:05 PM PDT | By Team Kalkine Media

UnitedHealth Group (NYSE: UNH) has announced its second quarter 2024 financial results, demonstrating robust performance driven by significant growth across its Optum and UnitedHealthcare segments. The company reported revenues totalling $98.9 billion, marking a nearly $6 billion increase year-over-year, with Optum leading the growth trajectory.

UnitedHealthcare's commercial domestic offerings saw an increase, serving an additional 2.3 million consumers year-to-date. The company's cash flows from operations stood at $6.7 billion, which equates to 1.5 times its net income.

In terms of earnings, UnitedHealth Group reported $4.54 per share for the second quarter. This figure reflects the impact of classifying its remaining South American operations as held for sale, as well as effects from a cyberattack.

Adjusted earnings per share were reported at $6.80, excluding $0.28 attributed to business disruption impacts. Costs related to South American operations and direct response were also excluded from this figure.

Looking ahead, UnitedHealth Group has revised its full-year 2024 net earnings outlook to be between $15.95 and $16.40 per share. This adjustment accounts for the classification of its remaining South American operations as held for sale, along with estimated impacts from the Change Healthcare cyberattack. The company completed the sale of its larger Brazilian operations in the first quarter of 2024.

Despite these adjustments, the company has maintained its adjusted net earnings outlook of $27.50 to $28.00 per share, which was initially established during its November 2023 Investor Conference. This outlook anticipates approximately $0.60 to $0.70 per share in business disruption impacts related to affected Change Healthcare services, an increase of $0.30 per share from previous estimates provided last quarter.

UnitedHealth Group's performance in the second quarter underscores its resilience in navigating both growth opportunities and challenges, positioning itself for continued stability and growth in the healthcare and insurance sectors.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next